PG
BSX icon

Proffitt & Goodson’s Boston Scientific BSX Stock Holding History

Proffitt & Goodson’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-61
Closed -$2K – 258
2020
Q4 		$2K Hold
61
– – ﹤0.01% 246
2020
Q3 		$2K Hold
61
– – ﹤0.01% 250
2020
Q2 		$2K Hold
61
– – ﹤0.01% 264
2020
Q1 		$2K Hold
61
– – ﹤0.01% 196
2019
Q4 		$3K Hold
61
– – ﹤0.01% 194
2019
Q3 		$2K Hold
61
– – ﹤0.01% 196
2019
Q2 		$3K Hold
61
– – ﹤0.01% 173
2019
Q1 		$2K Buy
+61
New +$2.33K ﹤0.01% 185
2018
Q4 		– Sell
-503
Closed -$19K – 182
2018
Q3 		$19K Buy
+503
New +$17.6K ﹤0.01% 97

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Proffitt & Goodson's BSX Position: Q1 2021 in Review

Proffitt & Goodson sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 61 shares — an estimated $2K sold.

Proffitt & Goodson first reported a position in BSX in Q3 2018 and held it in 9 quarters. The position peaked at $19K in Q3 2018. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Proffitt & Goodson reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Proffitt & Goodson sold 61 Boston Scientific shares in Q1 2021, an estimated $2K.
  • Proffitt & Goodson first reported a position in Boston Scientific in Q3 2018 and held it in 9 quarters.
  • Proffitt & Goodson's Boston Scientific position peaked at $19K in Q3 2018.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Proffitt & Goodson's 13F filing for Q1 2021, filed 3 May 2021.